BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10350482)

  • 1. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol.
    Dey S; Hafkemeyer P; Pastan I; Gottesman MM
    Biochemistry; 1999 May; 38(20):6630-9. PubMed ID: 10350482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological properties of an allosteric modulator site of the human P-glycoprotein (ABCB1).
    Maki N; Dey S
    Biochem Pharmacol; 2006 Jul; 72(2):145-55. PubMed ID: 16729976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
    Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy.
    Sauna ZE; Andrus MB; Turner TM; Ambudkar SV
    Biochemistry; 2004 Mar; 43(8):2262-71. PubMed ID: 14979722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of the human P-glycoprotein involves conformational changes mimicking catalytic transition intermediates.
    Ghosh P; Moitra K; Maki N; Dey S
    Arch Biochem Biophys; 2006 Jun; 450(1):100-12. PubMed ID: 16624245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.
    Dey S; Ramachandra M; Pastan I; Gottesman MM; Ambudkar SV
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10594-9. PubMed ID: 9380680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
    Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
    Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
    Maki N; Moitra K; Ghosh P; Dey S
    J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
    Maki N; Hafkemeyer P; Dey S
    J Biol Chem; 2003 May; 278(20):18132-9. PubMed ID: 12642584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of random recombination between human MDR1 and mouse mdr1a cDNA in a pHaMDR-dihydrofolate reductase bicistronic expression system.
    Shoshani T; Zhang S; Dey S; Pastan I; Gottesman MM
    Mol Pharmacol; 1998 Oct; 54(4):623-30. PubMed ID: 9765504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US
    Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent probes of the human multidrug transporter P-glycoprotein.
    Pires MM; Hrycyna CA; Chmielewski J
    Biochemistry; 2006 Sep; 45(38):11695-702. PubMed ID: 16981729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
    Wang Y; Georges E
    Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of the sixth transmembrane domain of Pgp1 by site-directed mutagenesis.
    Song J; Melera PW
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):339-46. PubMed ID: 11761450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein.
    Mandal D; Moitra K; Ghosh D; Xia D; Dey S
    Biochemistry; 2012 Apr; 51(13):2852-66. PubMed ID: 22360349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
    Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.